N-Triiodobenzoylaminoacyl polyhydroxic amines

Claim 2

A compound of the formula ##STR36## wherein X and Y are each nonionic functions compatible with low toxicity and/or water solubility in the 2,4,6-triiodo configuration, A is an amino substituted lower alkanoic acid coupler and ##STR37## is a monovalent residue of a polyhydroxy amine, wherein N is a nitrogen atom, R is hydrogen, lower alkyl, hydroxy-lower alkyl or polyhydroxy lower alkyl, Z is polyhydroxy lower alkyl or oxo polyhydroxy lower alkyl.

Claim 3

A compound as set forth in claim 1 wherein R is hydrogen or lower alkyl.

Claim 4

A compound as set forth in claim 1 wherein X and Y are each selected from the group consisting of lower alkoxy, hydroxy-(lower alkoxy), lower alkoxy-(lower alkoxy), lower acylamino, lower acylamino-(lower alkyl), lower acylamino-(lower acylamino), hydroxy-lower acylamino, N-(lower alkyl)-lower acylamino, lower alkyl-sulfonamido, N-(lower alkyl)-lower alkylsulfonamido, 3,3-bis(lower alkyl)-ureido, lower perfluoroacylamino, carbamyl, N-(lower alkyl) carbamyl, N-(hydroxy lower alkyl) carbamyl, N-(polyhydroxy lower alkyl) carbamyl, N,N-bis-(hydroxy lower alkyl) carbamyl, N,N-bis (polyhydroxy lower alkyl) carbamyl, N,N-di-(lower alkyl) carbamyl, lower alkoxy-(lower acylamino), lower alkoxy-alkoxy(lower acylamino), hydroxy and hydroxy lower alkyl functions.

Claim 5

A compound as set forth in claim 2 wherein one of X and Y is hydrogen lower alkoxy, hydroxy-(lower alkoxy), lower alkoxy-(lower alkoxy), lower acylamino, lower acylamino-(lower alkyl), lower acylamino-(lower acylamino), hydroxy-lower acylamino, N-(lower alkyl)-lower acylamino, lower alkylsulfonamido, N-(lower alkyl)-lower alkylsulfonamido, 3,3-bis(lower alkyl)-ureido, lower perfluoroacylamino, carbamyl, N-(lower alkyl) carbamyl, N-(hydroxy lower alkyl) carbamyl, N-(polyhydroxy lower alkyl) carbamyl, N,N-bis-(hydroxy lower alkyl) carbamyl, N,N-bis (polyhydroxy lower alkyl) carbamyl, N,N-di-(lower alkyl) carbamyl, lower alkoxy-(lower acylamino), lower alkoxy-alkoxy(lower acylamino), hydroxy or hydroxy lower alkyl and the other of X and Y is ##STR38## where A, N and Z are as defined above and R is hydrogen or lower alkyl.

Claim 6

A compound as set forth in claim 3 wherein X and Y are each selected from the group consisting of lower acylamino, N-(lower alkyl)-lower acylamino, carbamyl, N-(lower alkyl) carbamyl and N,N-di-(lower alkyl) carbamyl.

Claim 7

A compound as set forth in claim 1 wherein A is glycyl, R is hydrogen, Z is 2-(1,3,4,5,6-pentahydroxy-D-gluco-hexyl, X is acetamido and Y is N-methylacetamido.

Claim 8

A compound according to claim 1 wherein A is glycyl, R is hydrogen, Z is 2-(1,3,4,5,6-pentahydroxy-D-gluco-hexyl), X is acetamido and Y is methylcarbamyl.

Claim 9

A compound according to claim 1 wherein A is glycyl, R is methyl, Z is 2,3-dihydroxypropyl, X is acetamido, and Y is ##STR39## wherein A is glycyl, R is methyl, and Z is 2,3-dihydroxypropyl.

Claim 10

A compound according to claim 1 wherein A is glycyl, R is methyl, Z is 1-(2,3,4,5,6-pentahydroxy-D-gluco hexyl), X is acetamido, and Y is N-methylacetamido.

Claim 11

A radiological composition containing a compound of claim 1 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 12

In a method for X-ray visualization wherein a radiological composition containing an X-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter X-ray visualization carried out, the improvement comprising using as the radiological composition a composition containing a compound of claim 1 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 13

A compound as set forth in claim 2 wherein said monovalent residue is a residue selected from the group consisting of aldosamines, N-(lower alkyl) aldosamines, ketosamines, N-(lower alkyl) ketosamines, N-(polyhydroxy-lower alkyl) amines, N-alkyl-N-(polyhydroxy-lower alkoxy alkyl) amines, and deoxy-aldosamines.

Claim 14

A compound as set forth in claim 12 wherein A is glycyl.

Claim 15

A radiological composition containing the compound of claim 6 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 16

A radiological composition containing the compound of claim 7 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 17

A radiological composition containing the compound of claim 8 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 18

A radiological composition containing the compound of claim 9 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 19

A radiological composition containing a compound of claim 12 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 20

In a method for X-ray visualization wherein a radiological composition containing an X-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter X-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing a compound of claim 12 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 21

In a method for X-ray visualization wherein a radiological composition containing an X-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter X-ray visualization is carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 6 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 22

In a method for X-ray visualization wherein a radiological composition containing an X-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter X-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 7 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 23

In a method for X-ray visualization wherein a radiological composition containing an X-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter X-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 8 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 24

In a method for X-ray visualization wherein a radiological composition containing an X-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter X-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 9 in a sufficient amount to provide satisfactory X-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 25

A compound as set forth in claim 3 wherein one of X and Y is a lower acylamino, lower acylamino-(lower acylamino), hydroxy-lower acylamino, N-(lower alkyl)-lower acylamino, lower alkoxy-(lower acylamino) or lower alkoxy-alkoxy(lower acylamino) group and the other of X and Y is a lower acylamino, lower acylamino-(lower acylamino), hydroxy-lower acylamino, N-(lower alkyl)-lower acylamino, lower alkoxy-(lower acylamino), lower alkoxy-alkoxy(lower acylamino), carbamyl, N-(lower alkyl) carbamyl, N-(hydroxy lower alkyl) carbamyl, N-(polyhydroxy lower alkyl) carbamyl, N,N-bis-(hydroxy lower alkyl) carbamyl, N,N-bis-(hydroxy lower alkyl) carbamyl, N,N-bis-(polyhydroxy lower alkyl) carbamyl or N,N-di-(lower alkyl) carbamyl group.

Claim 26

A compound as set forth in claim 24 wherein ##STR40## is the monovalent rsidue of an aldosamine having the formula CHO--(CHOH) n --CHNH 2 --(CHOH) m --CH 2 OH where m is 0 to 4, n is 0 to 4 and the sum of m+n is 0 to 4; a N-lower alkyl aldosamine having the formula CHO--(CHOH) n --CHNHR--(CHOH) m --CH 2 OH where m is 0 to 4, n is 0 to 4, the sum of m+n is 0 to 4 and R is lower alkyl; a N-(polyhydroxy-lower alkyl) amine having the formula H--(CHOH) n --CHNH 2 --(CHOH) m --CH 2 OH where n is 0 to 5, m is 0 to 5 and the sum of n+m is 0 to 5; or a N-lower alkyl-N-(polyhydroxy lower alkyl) amine having the formula H--(CHOH) n --CHNHR--(CHOH) m --CH 2 OH where n is 0 to 2, m is 1 to 5, the sum of m+n is 1 to 5 and R is lower alkyl.

Claim 27

A compound as set forth in claim 25 wherein one of X and Y is lower acylamino, or N-(lower alkyl)-lower acylamino and the other of X and Y is lower acylamino, N-(lower alkyl)-lower acylamino, carbamyl, N-(lower alkyl) carbamyl, N,N di-(lower alkyl) carbamyl, or N(hydroxy lower alkyl) carbamyl.

Claim 28

A compound as set forth in claim 26 wherein A is glycyl.

Claim 29

A radiological composition containing the compound of claim 25 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 30

A radiological composition containing the compound of claim 26 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 31

In a method for x-ray visualization wherein a radiological composition containing an x-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter x-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 25 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 32

In a method for x-ray visualization wherein a radiological composition containing an x-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter x-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 26 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 33

A compound as set forth in claim 4 wherein one of X and Y is lower acylamino, lower acylamino-(lower acylamino), hydroxy-lower acylamino, N-(lower alkyl)-lower acylamino, lower alkoxy-(lower acylamino) or lower alkoxy-alkoxy (lower acylamino).

Claim 34

A compound as set forth in claim 32 wherein A is glycyl.

Claim 35

A radiological composition containing the compound of claim 4 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 36

A radiological composition containing the compound of claim 32 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle.

Claim 37

In a method for x-ray visualization wherein a radiological composition containing an x-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter x-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 4 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable radiological vehicle suitable for injection.

Claim 38

In a method for x-ray visualization wherein a radiological composition containing an x-ray contrast agent in a pharmaceutically acceptable radiological carrier is injected in a sufficient amount to provide adequate visualization and thereafter x-ray visualization carried out, the improvement comprising utilizing as the radiological composition a composition containing the compound of claim 32 in a sufficient amount to provide satisfactory x-ray visualization together with a pharmaceutically acceptable biological vehicle suitable for injection.